Ignite Creation Date:
2025-12-24 @ 12:56 PM
Ignite Modification Date:
2025-12-27 @ 10:19 PM
Study NCT ID:
NCT07023861
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-06-17
First Post:
2025-05-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
Sponsor:
Affiliated Hospital of Jiangnan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-07-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-12
First Submit QC Date:
None
Study First Post Date:
2025-06-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-14
Last Update Post Date:
2025-06-17
Last Update Post Date Type:
ACTUAL